69628-31-5 Usage
Molecular structure
The compound has a complex molecular structure with multiple functional groups and a core structure of pyrido[2,3-b][1,4]benzodiazepin-6-one.
Benzodioxol group
The compound contains a benzodioxol group, which is a fused ring system consisting of a benzene ring and a dioxole ring.
Piperazin-1-yl acetyl group
The compound has a piperazin-1-yl acetyl group, which is a derivative of the piperazine ring with an acetyl group attached.
5-methyl substitution
The compound has a methyl group substitution at the 5-position of the pyrido[2,3-b][1,4]benzodiazepin-6-one core.
11-acylation
The compound has an acylation at the 11-position with a [4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]acetyl group.
Potential pharmaceutical properties
Due to its structure, the compound is likely to have pharmaceutical properties, potentially affecting the central nervous system.
Sedative or anxiolytic effects
The compound may exhibit sedative or anxiolytic effects, which are calming and anxiety-reducing properties.
Further research needed
More research and analysis are required to fully understand the properties and potential uses of this chemical compound.
Molecular weight
The molecular weight of the compound is approximately 480.52 g/mol.
Appearance
The compound is likely to be a solid, with a specific color and appearance that may vary depending on its purity and form.
Solubility
The solubility of the compound in various solvents is not provided, but it may be soluble in some organic solvents and less soluble in water.
Stability
The stability of the compound under different conditions, such as temperature, pH, and light exposure, is not provided and would require further investigation.
Synthesis
The synthesis of the compound involves the formation of the pyrido[2,3-b][1,4]benzodiazepin-6-one core and the subsequent introduction of the various functional groups, such as the benzodioxol group and the piperazin-1-yl acetyl group.
Potential applications
The compound may have potential applications in the pharmaceutical industry, particularly in the development of drugs targeting the central nervous system. However, further research is needed to confirm its efficacy and safety.
Check Digit Verification of cas no
The CAS Registry Mumber 69628-31-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,6,2 and 8 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 69628-31:
(7*6)+(6*9)+(5*6)+(4*2)+(3*8)+(2*3)+(1*1)=165
165 % 10 = 5
So 69628-31-5 is a valid CAS Registry Number.
69628-31-5Relevant articles and documents
11-(Piperazino-acetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-ones and salts thereof
-
, (2008/06/13)
Compounds of the formula STR1 wherein R1 is alkyl of 3 to 12 carbon atoms; unsaturated aliphatic hydrocarbyl of 3 to 20 carbon atoms comprising 1 to 3 double bonds and/or one triple bond; phenyl(alkyl of 2 to 4 carbon atoms); methylenedioxybenz
